Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.05.024Source: DataRank Database

Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals is a research paper published in Clinical Gastroenterology and Hepatology (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 2.11)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ali Hajjar ORCID,Peter P. Mueller ORCID,Gizem Sultan Nemutlu ORCID,Neeti Kulkarni,Mary Linton B. Peters ORCID

Live enrichment

PubMed:37302445 PMC:PMC10709527 OpenAlex:https://openalex.org/W4380183577

US Department of Defense

Grant: W81XWH-19-10689

US Department of Defense

Grant: W81XWH-19-10690

American Cancer Society

Grant: RSG-17-022-01-CPPB

National Cancer Institute

Grant: K08 CA248473

National Cancer Institute

Grant: P30 DK 56338

National Cancer Institute

Grant: R01CA186566

National Cancer Institute

Grant: U01CA230997

Cancer Prevention and Research Institute of Texas

Grant: RP150587

NIDDK NIH HHS

Grant: P30 DK056338

National Institutes of Health

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10709527/pdf/nihms-1909224.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1542356523004469?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356523004469?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10709527

Fields of Study

Hepatitis C virus researchHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

MeSH Terms

Antiviral AgentsHepatitis CCarcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsIncidenceHepacivirusHepatitis C, Chronic

Keywords

MedicineHepatocellular carcinomaIncidence (geometry)CirrhosisHepatitis CInternal medicineHepatitis BGastroenterologyOncologyLiver cancerScreeningPreventionCost-effectiveness Analysis

Sustainable Development Goals

SDG 0: Good health and well-being